在HFrEF患者中,将右心室节奏升级为心脏再同步改善了症状和功能结果
Eperke Merkel1, Robert Hatala2, Mátyás Szigeti1
1Semmelweis University, Heart and Vascular Center, Budapest, Hungary.
JACC. Heart failure
|November 30, 2024
概括
心脏再同步疗法 (CRT) 升级显著改善了心力衰竭症状和生活质量在患有高右心室节奏负担的患者. 这种升级还降低了性尿素水平,提供了超越标准设备治疗的好处.
科学领域:
- 心脏病学 心脏病学
- 电力生理学 电力生理学
- 心脏衰竭管理的管理
背景情况:
- 高右心室 (RV) 节奏负担在心力衰竭患者减少喷射分数 (HFrEF) 可以导致不利的改造.
- 心脏再同步治疗 (CRT) 在HFrEF中显示出好处,但其作为高RV节奏患者升级的作用不太清楚.
研究的目的:
- 评估CRT升级对显著RV节奏的HFrEF患者的症状,功能状态和运动能力的影响.
- 为了评估生活质量 (QoL),NYHA功能类,6分钟步行测试和NT-proBNP水平的变化.
主要方法:
- 布达佩斯-CRT升级试验随机选择了360名HFrEF患者,其中≥20%的RV节奏被升级为CRT与除器 (CRT-D) 升级或标准ICD.
- 三级终点包括QOL的EQ-5D-3L变化,NYHA类,6分钟步行测试和12个月的NT-proBNP水平.
主要成果:
- 与单独使用ICD相比,CRT-D升级导致NYHA功能类显著改善 (OR:0.50;P=0.003).
- 在CRT-D手臂中观察到NT-proBNP水平的显著降低 (差异: -1,257 pg/mL;P=0.017).
- CRT-D升级缓和了与年龄相关的QOL下降 (P-相互作用=0.003),但运动耐受性 (6分钟步行测试) 保持不变.
结论:
- 在高RV节奏负担的HFrEF患者中,CRT升级显著改善了功能类,并降低了与单独ICD相比的尿素水平.
- 升级CRT-D提供了一种潜在的策略,以减轻与这个患者群体老龄化相关的生活质量恶化.
相关概念视频
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
386
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
386
01:21Rheumatic Heart Disease III: Medical Management
3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
01:20Mitral Regurgitation I: Introduction
4
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
4
01:22Heart Failure Drugs: β-Blockers
316
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
316